PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.34%
Revenue growth of 2.34% while ON is flat. Bruce Berkowitz would check if a small edge can widen further.
1.44%
Gross profit growth of 1.44% while ON is zero. Bruce Berkowitz would see if minimal improvements could expand further.
10.06%
EBIT growth of 10.06% while ON is zero. Bruce Berkowitz would see if small gains can be scaled further.
9.27%
Operating income growth of 9.27% while ON is zero. Bruce Berkowitz would see if this modest edge can become significant.
-7.68%
Negative net income growth while ON stands at 0.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-3.85%
Negative EPS growth while ON is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-4.00%
Negative diluted EPS growth while ON is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-5.29%
Share reduction while ON is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-4.04%
Reduced diluted shares while ON is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
8.69%
Dividend growth of 8.69% while ON is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-58.68%
Negative OCF growth while ON is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-152.53%
Negative FCF growth while ON is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
43.68%
10Y CAGR of 43.68% while ON is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
-12.20%
Negative 5Y CAGR while ON stands at 0.00%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
14.04%
3Y CAGR of 14.04% while ON is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
322.80%
OCF/share CAGR of 322.80% while ON is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
57.02%
OCF/share CAGR of 57.02% while ON is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
29.13%
3Y OCF/share CAGR of 29.13% while ON is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
2488.56%
10Y net income/share CAGR of 2488.56% while ON is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
66.59%
Net income/share CAGR of 66.59% while ON is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
205.05%
3Y net income/share CAGR of 205.05% while ON is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
261.53%
Equity/share CAGR of 261.53% while ON is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
211.41%
Equity/share CAGR of 211.41% while ON is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
147.24%
Equity/share CAGR of 147.24% while ON is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
16.57%
Dividend/share CAGR of 16.57% while ON is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
38.50%
Dividend/share CAGR of 38.50% while ON is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
2.24%
3Y dividend/share CAGR of 2.24% while ON is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
0.10%
AR growth of 0.10% while ON is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
4.81%
Inventory growth of 4.81% while ON is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
16.45%
Asset growth of 16.45% while ON is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
27.76%
BV/share growth of 27.76% while ON is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
-2.41%
We’re deleveraging while ON stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
18.99%
R&D growth of 18.99% while ON is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
-18.83%
We cut SG&A while ON invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.